Rocket Companies (Nasdaq: RKT) reports Q2 earnings after the close with a call scheduled for 4:30 PM ET. Analysts expect revenue of $1.28 billion and normalized EPS of $0.03 — down 50% YoY despite a ...

Key Points Revenue (GAAP) surpassed expectations at $249 million for Q2 2025, marking a 4% year-over-year increase. Non-GAAP earnings per share reached $0.25 for Q2 2025, beating estimates, with ...

Impinj stock soared more than 34% after beating analyst expectations in its Q2 earnings report. Revenue and earnings both ...

Investors may want to keep close tabs on CHKP stock. During the business week beginning Oct. 28, 2024, Check Point suffered a ...

Pulmonx (NASDAQ:LUNG) stock drops 41% as Q2 results reveal a lowered revenue outlook, which has led Piper Sandler to ...

Key Points GAAP revenue of $1.67 billion in Q1 FY2026 topped estimates by $0.18 billion and exceeded management's guidance midpoint by $71 million. Earnings per share were $0.79, outpacing the $0.75 ...

As Meta Platforms shifts focus and rides a bullish trend, investors should formulate a strategy for all likely outcomes. 24/7 ...

Alnylam Pharmaceuticals, Inc. shares soar with strong Q2 results, driven by Amvuttra's stellar U.S. launch for ATTR ...

Key Points Lam Research reported non-GAAP revenue and profits that far exceeded analyst expectations for Q2 FY2025. Revenue increased 33.6% year over year for Q4 FY2025. Both gross margin and ...

Itron upgraded at JPMorgan after reporting better than expected Q2 earnings while issuing above-consensus guidance for FY 2025 earnings but below consensus for full-year revenues.

Sprouts Farmers Market sailed past analysts' expectations with its second-quarter earnings. Revenue grew by 17%, same-store ...

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is one of the best strong buy stocks to buy under $10. In a report released on ...